Based on analysts offering 12 month price targets for BIMO in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

By David Bautz, PhD NASDAQ:ABEO READ THE FULL ABEO RESEARCH REPORT Business Update FDA Inspection and BLA Mid-Cycle Review Meeting Completed On February 1, 2024, Abeona Therapeutics, Inc. (NASDAQ ...